Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 142.2M | 140.7M | 152.2M |
Cost of revenue | — | 17.9M | 18.9M | 31.1M |
Gross profit | 123.2M | 124.4M | 121.8M | 121.0M |
Operating expense | ||||
Research & development | — | 92.4M | 90.6M | 90.2M |
Selling general and admin | — | 38.0M | 35.3M | 35.6M |
Other operating expenses | — | — | — | — |
Operating income | — | -6.1M | -4.1M | -4.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.7M | -4.6M | -2.1M | -2.8M |
Tax provision | — | 1.1M | 2.3M | -448K |
Net income | — | -5.7M | -4.4M | -2.3M |
Basic EPS | — | 0.0 | 0.0 | 0.0 |
Diluted EPS | — | 0.0 | 0.0 | 0.0 |
Basic average shares | — | 229.0M | 219.0M | 231.2M |
Diluted average shares | 301.4M | 229.0M | 219.0M | 231.2M |
EBITDA | — | 2.9M | 4.7M | 4.7M |
Net income from continuing op. | — | -6.1M | -4.1M | -5.2M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 0 | 0 | 0 |